
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period:
In recent years, aptamers have also been used as biological recognition components in the case of specific detection and enzymes in the case of total protein detection in biosensors for protein detection, which still primarily use antibodies.
Potential techniques for homogenous tests include protein sensors based on allosteric enzymes that vary their enzymatic activity quickly in response to target binding.
However, it is challenging to build them so that they have a high signal-to-noise ratio (S/N).
The level of a particular protein is measured using an enzyme-linked immunosorbent assay (ELISA), which uses a microplate format. Results are typically observed via absorbance in the visible wavelength range.
Biological research, clinical diagnosis, and treatment all involve protein detection. Analysing the quantity and concentration of various proteins in a given specimen is known as protein detection.
In many organisms, protein can be found using a variety of techniques and approaches.
The Global Protein detection sensor market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Launch of a technology by Merck for highly sensitive protein detection With the introduction of SMCxPRO technology, Merck KGaA has introduced its newest high-sensitivity protein detection platform.
Researchers can now assess low-abundance biomarkers using the SMCxPRO platform, which is able to identify and quantify them.
The device has a quick, accurate, high-sensitivity detecting technology that is compact in design.
Along with its recently published Sanger CRISPR libraries, which increase the company's arsenal of gene editing tools, Merck provides a wide range of options for biomarker discovery and the identification of novel targets in addition to the new SMCxPRO technology.
SMCxPRO technology, the newest breakthrough from Merck, is a component of a set of instruments for identifying and characterising, speeding up drug discovery, and enhancing overall lab productivity.
Quantitation of a new class of unique targets is made possible by the detection of low-abundance biomarkers. They are dedicated to empowering researchers by offering the tools required to hasten medical discoveries.
THIS REPORT WILL ANSWER FOLLOWING QUESTIONS OFPROTEIN DETECTION SENSOR MARKET
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |